Literature DB >> 15498923

Subcellular localization as a limiting factor for utilization of decoy oligonucleotides.

Anca Bene1, Richard C Kurten, Timothy C Chambers.   

Abstract

Transfection of cells with short double-stranded synthetic DNA molecules that contain a transcription factor binding site, known as decoy oligodeoxynucleotides (ODNs), has been proposed as a novel approach in vitro and in vivo for the study of gene regulation and for gene therapy. Once delivered into cells, decoy ODNs are predicted to bind to nuclear transcription factors, preventing their binding to consensus sequences in target genes. Using a fluorescein-labeled decoy ODN containing a consensus sequence for the AP-1 transcription factor, we show that lipid-complexed decoys were readily transfectable into cells, but were consistently detectable in the cytoplasm and not in the nucleus. The same phenomenon was observed in three different cell lines including KB-3, CHO and MDA-MB-231. The AP-1 decoy ODNs failed to inhibit the transcriptional activity of an AP-1-dependent luciferase reporter. The effect of cytoplasmic AP-1 decoy ODNs on the subcellular localization and function of c-Jun induced by the microtubule inhibitor vinblastine, which strongly induced c-Jun expression, was assessed. No difference in protein level or nuclear localization of vinblastine-induced c-Jun, or of one of its target genes, p53, was noted when cells were transfected with wild-type or mutated forms of the decoy ODNs. We suggest that subcellular localization is an unappreciated and key limiting factor for the use of transcription factor decoy ODNs that must be addressed before meaningful data interpretation can be made.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15498923      PMCID: PMC528816          DOI: 10.1093/nar/gnh139

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  19 in total

1.  Administration of a decoy against the activator protein-1 binding site suppresses neointimal thickening in rabbit balloon-injured arteries.

Authors:  Masazumi Kume; Kimihiro Komori; Takuya Matsumoto; Toshihiro Onohara; Kensuke Takeuchi; Yoshikazu Yonemitsu; Keizo Sugimachi
Journal:  Circulation       Date:  2002-03-12       Impact factor: 29.690

2.  Decoy oligodeoxynucleotide characterization of transcription factors controlling endothelin-B receptor expression in vascular smooth muscle cells.

Authors:  A H Wagner; R Krzesz; D Gao; C Schroeder; M Cattaruzza; M Hecker
Journal:  Mol Pharmacol       Date:  2000-12       Impact factor: 4.436

3.  Inhibition of mesangial cell proliferation by E2F decoy oligodeoxynucleotide in vitro and in vivo.

Authors:  Y Maeshima; N Kashihara; T Yasuda; H Sugiyama; T Sekikawa; K Okamoto; K Kanao; Y Watanabe; Y S Kanwar; H Makino
Journal:  J Clin Invest       Date:  1998-06-01       Impact factor: 14.808

4.  Role of AP-1 complex in angiotensin II-mediated transforming growth factor-beta expression and growth of smooth muscle cells: using decoy approach against AP-1 binding site.

Authors:  R Morishita; G H Gibbons; M Horiuchi; Y Kaneda; T Ogihara; V J Dzau
Journal:  Biochem Biophys Res Commun       Date:  1998-02-13       Impact factor: 3.575

5.  Transcription factor decoy for NFkappaB inhibits cytokine and adhesion molecule expressions in synovial cells derived from rheumatoid arthritis.

Authors:  T Tomita; H Takano; N Tomita; R Morishita; M Kaneko; K Shi; K Takahi; T Nakase; Y Kaneda; H Yoshikawa; T Ochi
Journal:  Rheumatology (Oxford)       Date:  2000-07       Impact factor: 7.580

6.  Transcription factor decoy for NFkappaB inhibits TNF-alpha-induced cytokine and adhesion molecule expression in vivo.

Authors:  N Tomita; R Morishita; S Tomita; G H Gibbons; L Zhang; M Horiuchi; Y Kaneda; J Higaki; T Ogihara; V J Dzau
Journal:  Gene Ther       Date:  2000-08       Impact factor: 5.250

7.  Control of cell cycle progression by c-Jun is p53 dependent.

Authors:  M Schreiber; A Kolbus; F Piu; A Szabowski; U Möhle-Steinlein; J Tian; M Karin; P Angel; E F Wagner
Journal:  Genes Dev       Date:  1999-03-01       Impact factor: 11.361

8.  The c-Jun NH(2)-terminal protein kinase/AP-1 pathway is required for efficient apoptosis induced by vinblastine.

Authors:  M Fan; M E Goodwin; M J Birrer; T C Chambers
Journal:  Cancer Res       Date:  2001-06-01       Impact factor: 12.701

9.  AP-1 activation and altered AP-1 composition in association with increased phosphorylation and expression of specific Jun and Fos family proteins induced by vinblastine in KB-3 cells.

Authors:  A Berry; M Goodwin; C L Moran; T C Chambers
Journal:  Biochem Pharmacol       Date:  2001-09-01       Impact factor: 5.858

10.  Dual blockade of cyclic AMP response element- (CRE) and AP-1-directed transcription by CRE-transcription factor decoy oligonucleotide. gene-specific inhibition of tumor growth.

Authors:  Y G Park; M Nesterova; S Agrawal; Y S Cho-Chung
Journal:  J Biol Chem       Date:  1999-01-15       Impact factor: 5.157

View more
  4 in total

Review 1.  STAT3 inhibitors for cancer therapy: Have all roads been explored?

Authors:  Remi Fagard; Valeri Metelev; Inès Souissi; Fanny Baran-Marszak
Journal:  JAKSTAT       Date:  2013-01-01

2.  A STAT3-decoy oligonucleotide induces cell death in a human colorectal carcinoma cell line by blocking nuclear transfer of STAT3 and STAT3-bound NF-κB.

Authors:  Inès Souissi; Imen Najjar; Laurent Ah-Koon; Pierre Olivier Schischmanoff; Denis Lesage; Stéphanie Le Coquil; Claudine Roger; Isabelle Dusanter-Fourt; Nadine Varin-Blank; An Cao; Valeri Metelev; Fanny Baran-Marszak; Remi Fagard
Journal:  BMC Cell Biol       Date:  2011-04-12       Impact factor: 4.241

3.  Targeted disruption of transcriptional regulatory function of p53 by a novel efficient method for introducing a decoy oligonucleotide into nuclei.

Authors:  Masakiyo Sakaguchi; Takamasa Nukui; Hiroyuki Sonegawa; Hitoshi Murata; Junichiro Futami; Hidenori Yamada; Nam-ho Huh
Journal:  Nucleic Acids Res       Date:  2005-05-26       Impact factor: 16.971

4.  AP-1 Oligodeoxynucleotides Reduce Aortic Elastolysis in a Murine Model of Marfan Syndrome.

Authors:  Rawa Arif; Marcin Zaradzki; Anca Remes; Philipp Seppelt; Reiner Kunze; Hannes Schröder; Simon Schwill; Stephan M Ensminger; Peter N Robinson; Matthias Karck; Oliver J Müller; Markus Hecker; Andreas H Wagner; Klaus Kallenbach
Journal:  Mol Ther Nucleic Acids       Date:  2017-09-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.